Full Text Available
Note: Clicking the button above will open the full text document at the original institutional repository in a new window.
Metabolic dysfunction–associated steatotic liver disease and cardiovascular disease: Emerging insights into the liver–heart axis
Saved in:
| Published in: | Journal of Diabetes Investigation |
|---|---|
| Format: | Online Article RSS Article |
| Published: |
2026
|
| Subjects: | |
| Tags: |
No Tags, Be the first to tag this record!
|
Similar Items: Metabolic dysfunction–associated steatotic liver disease and cardiovascular disease: Emerging insights into the liver–heart axis
- Metabolic dysfunction-associated steatotic liver disease: pathogenesis and novel treatment options
- Heart starts suffering early in sickle cell disease
- Metabolic Dysfunction–Associated Steatotic Liver Disease and Respiratory Disorders: A Systematic Review of Clinical and Pathophysiological Associations
- Melatonin targets mitochondrial trifunctional enzyme HADHA to improve lipid metabolism in metabolic dysfunction-associated steatotic liver disease
- Resistance Training in Cardiovascular Diseases: A Review on Its Effectiveness in Controlling Risk Factors
- Cardiovascular Disease, Cancer and Dementia in Diabetes: 20‐Year Trends Will Necessitate New Treatment Priorities